Neo Ivy Capital Management Corcept Therapeutics Inc Transaction History

Neo Ivy Capital Management

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 29, 2023	SELL	$21.97 - $33.8 $47,850 - $73,616	-2,178 Reduced 47.33%	2,424 $66,000
Q2 2023 Aug 15, 2023	SELL	$21.44 - $25.15 $379,745 - $445,456	-17,712 Reduced 79.38%	4,602 $102,000
Q4 2022 Mar 24, 2023	BUY	$19.95 - $29.96 $443,987 - $666,759	22,255 Added 37720.34%	22,314 $453,000
Q3 2022 Nov 15, 2022	BUY	$24.7 - $29.12 $1,457 - $1,718	59 New	59 $2,000
Q2 2022 Aug 16, 2022	SELL	$17.33 - $25.3 $86,303 - $125,994	-4,980 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$16.53 - $25.21 $82,319 - $125,545	4,980 New	4,980 $112,000
Q3 2021 Nov 16, 2021	SELL	$19.68 - $22.53 $30,090 - $34,448	-1,529 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$19.97 - $24.43 $237,443 - $290,472	-11,890 Reduced 88.61%	1,529 $34,000
Q1 2021 Oct 07, 2021	BUY	$23.49 - $30.56 $315,212 - $410,084	13,419 New	13,419 $319,000
Q4 2020 Feb 16, 2021	SELL	$16.78 - $27.3 $8,557 - $13,923	-510 Closed	0 $0
Q3 2020 Nov 17, 2020	BUY	$12.46 - $19.98 $6,354 - $10,189	510 New	510 $8,000

355

86.2M

1.12M

667K

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $7.17B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

Get notified when there are updates to the investment portfolio of Neo Ivy Capital Management, based on Form 13F filings with the SEC.

Stay updated on Neo Ivy Capital Management with notifications on news.